HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8.

Abstract
There is currently growing interest in retargeting of effector T cells to tumor cells via bispecific antibodies (bsAbs). Usually, bsAbs are directed on the one hand to the CD3 complex of T cells and on the other hand to a molecule expressed on the surface of the target cell. A bsAb-mediated cross-linkage via CD3 leads to an activation of CD8+ T cells and consequently to killing of the target cells. In parallel, CD4+ T cells including TH1, TH2, TH17 cells and even regulatory T cells (Tregs) will be activated as well. Cytokines produced by CD4+ T cells can contribute to severe side effects e. g. life-threatening cytokine storms and, thinking of the immunosupressive function of Tregs, can even be counterproductive. Therefore, we asked whether or not it is feasible to limit retargeting to CD8+ T cells e. g. via targeting of the co-receptor CD8 instead of CD3. In order to test for proof of concept, a novel bsAb with specificity for CD8 and a tumor-associated surface antigen was constructed. Interestingly, we found that pre-activated (but not freshly isolated) CD8+ T cells can be retargeted via CD8-engaging bsAbs leading to an efficient lysis of target cells.
AuthorsIrene Michalk, Anja Feldmann, Stefanie Koristka, Claudia Arndt, Marc Cartellieri, Armin Ehninger, Gerhard Ehninger, Michael P Bachmann
JournalPloS one (PLoS One) Vol. 9 Issue 4 Pg. e95517 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24751697 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bispecific
  • CD3 Complex
  • CD8 Antigens
  • Cross-Linking Reagents
  • Cytokines
  • Receptors, Antigen, T-Cell
  • Single-Chain Antibodies
Topics
  • Animals
  • Antibodies, Bispecific (immunology, isolation & purification)
  • CD3 Complex (metabolism)
  • CD8 Antigens (metabolism)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cell Line
  • Cell Separation
  • Cross-Linking Reagents (metabolism)
  • Cytokines (metabolism)
  • Cytotoxicity, Immunologic (immunology)
  • Humans
  • Lymphocyte Activation (immunology)
  • Mice
  • Neoplasms (immunology, pathology)
  • Protein Binding
  • Receptors, Antigen, T-Cell (metabolism)
  • Single-Chain Antibodies (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: